Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 203 entries
Sorted by: Best Match Show Resources per page
Finding and fixing diagnosis errors: can triggers help?.

BMJ quality & safety

Schiff GD.
PMID: 22129932
BMJ Qual Saf. 2012 Feb;21(2):89-92. doi: 10.1136/bmjqs-2011-000590. Epub 2011 Nov 30.

No abstract available.

Cite
Schiff GD. Finding and fixing diagnosis errors: can triggers help?. BMJ Qual Saf. 2011;21(2):89-92doi: 10.1136/bmjqs-2011-000590.
Schiff, G. D. (2012). Finding and fixing diagnosis errors: can triggers help?. BMJ quality & safety, 21(2), 89-92. https://doi.org/10.1136/bmjqs-2011-000590
Schiff, Gordon D. "Finding and fixing diagnosis errors: can triggers help?." BMJ quality & safety vol. 21,2 (2012): 89-92. doi: https://doi.org/10.1136/bmjqs-2011-000590
Schiff GD. Finding and fixing diagnosis errors: can triggers help?. BMJ Qual Saf. 2012 Feb;21(2):89-92. doi: 10.1136/bmjqs-2011-000590. Epub 2011 Nov 30. PMID: 22129932.
Copy Download .nbib Format: NLM
Nonlinear photocarrier drift in hydrogenated amorphous silicon-germanium alloys.

Physical review. B, Condensed matter

Antoniadis H, Schiff EA.
PMID: 9997263
Phys Rev B Condens Matter. 1991 Jun 15;43(17):13957-13966. doi: 10.1103/physrevb.43.13957.

No abstract available.

Cite
Antoniadis H, Schiff EA. Nonlinear photocarrier drift in hydrogenated amorphous silicon-germanium alloys. Phys Rev B Condens Matter. 1991;43(17):13957-13966doi: 10.1103/physrevb.43.13957.
Antoniadis, H., & Schiff, E. A. (1991). Nonlinear photocarrier drift in hydrogenated amorphous silicon-germanium alloys. Physical review. B, Condensed matter, 43(17), 13957-13966. https://doi.org/10.1103/physrevb.43.13957
Antoniadis, and Schiff. "Nonlinear photocarrier drift in hydrogenated amorphous silicon-germanium alloys." Physical review. B, Condensed matter vol. 43,17 (1991): 13957-13966. doi: https://doi.org/10.1103/physrevb.43.13957
Antoniadis H, Schiff EA. Nonlinear photocarrier drift in hydrogenated amorphous silicon-germanium alloys. Phys Rev B Condens Matter. 1991 Jun 15;43(17):13957-13966. doi: 10.1103/physrevb.43.13957. PMID: 9997263.
Copy Download .nbib Format: NLM
Hydrogen-mediated model for defect metastability in hydrogenated amorphous silicon.

Physical review. B, Condensed matter

Schiff EA, Zafar S.
PMID: 9992539
Phys Rev B Condens Matter. 1989 Sep 01;40(7):5235-5238. doi: 10.1103/physrevb.40.5235.

No abstract available.

Cite
Schiff EA, Zafar S. Hydrogen-mediated model for defect metastability in hydrogenated amorphous silicon. Phys Rev B Condens Matter. 1989;40(7):5235-5238doi: 10.1103/physrevb.40.5235.
Schiff, E. A., & Zafar, S. (1989). Hydrogen-mediated model for defect metastability in hydrogenated amorphous silicon. Physical review. B, Condensed matter, 40(7), 5235-5238. https://doi.org/10.1103/physrevb.40.5235
Schiff, and Zafar. "Hydrogen-mediated model for defect metastability in hydrogenated amorphous silicon." Physical review. B, Condensed matter vol. 40,7 (1989): 5235-5238. doi: https://doi.org/10.1103/physrevb.40.5235
Schiff EA, Zafar S. Hydrogen-mediated model for defect metastability in hydrogenated amorphous silicon. Phys Rev B Condens Matter. 1989 Sep 01;40(7):5235-5238. doi: 10.1103/physrevb.40.5235. PMID: 9992539.
Copy Download .nbib Format: NLM
Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN.
PMID: 31371312
Clin Cancer Res. 2019 Aug 01;25(15):4862. doi: 10.1158/1078-0432.CCR-19-2052.

No abstract available.

Cite
Schiff BA, McMurphy AB, Jasser SA, et al. Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer. Clin Cancer Res. 2019;25(15):4862doi: 10.1158/1078-0432.CCR-19-2052.
Schiff, B. A., McMurphy, A. B., Jasser, S. A., Younes, M. N., Doan, D., Yigitbasi, O. G., Kim, S., Zhou, G., Mandal, M., Bekele, B. N., Holsinger, F. C., Sherman, S. I., Yeung, S. C., El-Naggar, A. K., & Myers, J. N. (2019). Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 25(15), 4862. https://doi.org/10.1158/1078-0432.CCR-19-2052
Schiff, Bradley A, et al. "Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25,15 (2019): 4862. doi: https://doi.org/10.1158/1078-0432.CCR-19-2052
Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN. Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer. Clin Cancer Res. 2019 Aug 01;25(15):4862. doi: 10.1158/1078-0432.CCR-19-2052. PMID: 31371312.
Copy Download .nbib Format: NLM
Maternal Health in the United States.

The New England journal of medicine

Schiff DM, Patrick SW, Terplan M.
PMID: 29419278
N Engl J Med. 2018 Feb 08;378(6):587. doi: 10.1056/NEJMc1715957.

No abstract available.

Cite
Schiff DM, Patrick SW, Terplan M. Maternal Health in the United States. N Engl J Med. 2018;378(6):587doi: 10.1056/NEJMc1715957.
Schiff, D. M., Patrick, S. W., & Terplan, M. (2018). Maternal Health in the United States. The New England journal of medicine, 378(6), 587. https://doi.org/10.1056/NEJMc1715957
Schiff, Davida M, et al. "Maternal Health in the United States." The New England journal of medicine vol. 378,6 (2018): 587. doi: https://doi.org/10.1056/NEJMc1715957
Schiff DM, Patrick SW, Terplan M. Maternal Health in the United States. N Engl J Med. 2018 Feb 08;378(6):587. doi: 10.1056/NEJMc1715957. PMID: 29419278.
Copy Download .nbib Format: NLM
Methodologies for evaluating strategies to reduce diagnostic error: report from the research summit at the 7th International Diagnostic Error in Medicine Conference.

Diagnosis (Berlin, Germany)

Bruce BB, El-Kareh R, Ely JW, Kanter MH, Rao G, Schiff GD, Ten Berg MJ, McDonald KM.
PMID: 29540046
Diagnosis (Berl). 2016 Mar 01;3(1):1-7. doi: 10.1515/dx-2016-0002.

In this article we review current evidence on strategies to evaluate diagnostic error solutions, discuss the methodological challenges that exist in investigating the value of these strategies in patient care, and provide recommendations for methods that can be applied...

Cite
Bruce BB, El-Kareh R, Ely JW, et al. Methodologies for evaluating strategies to reduce diagnostic error: report from the research summit at the 7th International Diagnostic Error in Medicine Conference. Diagnosis (Berl). 2016;3(1):1-7doi: 10.1515/dx-2016-0002.
Bruce, B. B., El-Kareh, R., Ely, J. W., Kanter, M. H., Rao, G., Schiff, G. D., Ten Berg, M. J., & McDonald, K. M. (2016). Methodologies for evaluating strategies to reduce diagnostic error: report from the research summit at the 7th International Diagnostic Error in Medicine Conference. Diagnosis (Berlin, Germany), 3(1), 1-7. https://doi.org/10.1515/dx-2016-0002
Bruce, Beau B, et al. "Methodologies for evaluating strategies to reduce diagnostic error: report from the research summit at the 7th International Diagnostic Error in Medicine Conference." Diagnosis (Berlin, Germany) vol. 3,1 (2016): 1-7. doi: https://doi.org/10.1515/dx-2016-0002
Bruce BB, El-Kareh R, Ely JW, Kanter MH, Rao G, Schiff GD, Ten Berg MJ, McDonald KM. Methodologies for evaluating strategies to reduce diagnostic error: report from the research summit at the 7th International Diagnostic Error in Medicine Conference. Diagnosis (Berl). 2016 Mar 01;3(1):1-7. doi: 10.1515/dx-2016-0002. PMID: 29540046.
Copy Download .nbib Format: NLM
Primary Care Collaboration to Improve Diagnosis and Screening for Colorectal Cancer.

Joint Commission journal on quality and patient safety

Schiff GD, Bearden T, Hunt LS, Azzara J, Larmon J, Phillips RS, Singer S, Bennett B, Sugarman JR, Bitton A, Ellner A.
PMID: 28648219
Jt Comm J Qual Patient Saf. 2017 Jul;43(7):338-350. doi: 10.1016/j.jcjq.2017.03.004. Epub 2017 Apr 19.

BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer death, reducible by screening and early diagnosis, yet many patients fail to receive recommended screening. As part of an academic improvement collaborative, 25 primary care practices worked to improve...

Cite
Schiff GD, Bearden T, Hunt LS, et al. Primary Care Collaboration to Improve Diagnosis and Screening for Colorectal Cancer. Jt Comm J Qual Patient Saf. 2017;43(7):338-350doi: 10.1016/j.jcjq.2017.03.004.
Schiff, G. D., Bearden, T., Hunt, L. S., Azzara, J., Larmon, J., Phillips, R. S., Singer, S., Bennett, B., Sugarman, J. R., Bitton, A., & Ellner, A. (2017). Primary Care Collaboration to Improve Diagnosis and Screening for Colorectal Cancer. Joint Commission journal on quality and patient safety, 43(7), 338-350. https://doi.org/10.1016/j.jcjq.2017.03.004
Schiff, Gordon D, et al. "Primary Care Collaboration to Improve Diagnosis and Screening for Colorectal Cancer." Joint Commission journal on quality and patient safety vol. 43,7 (2017): 338-350. doi: https://doi.org/10.1016/j.jcjq.2017.03.004
Schiff GD, Bearden T, Hunt LS, Azzara J, Larmon J, Phillips RS, Singer S, Bennett B, Sugarman JR, Bitton A, Ellner A. Primary Care Collaboration to Improve Diagnosis and Screening for Colorectal Cancer. Jt Comm J Qual Patient Saf. 2017 Jul;43(7):338-350. doi: 10.1016/j.jcjq.2017.03.004. Epub 2017 Apr 19. PMID: 28648219.
Copy Download .nbib Format: NLM
Detailed Phenotyping and Therapeutic Strategies for Intronic ABCA4 Variants in Stargardt Disease.

Molecular therapy. Nucleic acids

Khan M, Arno G, Fakin A, Parfitt DA, Dhooge PPA, Albert S, Bax NM, Duijkers L, Niblock M, Hau KL, Bloch E, Schiff ER, Piccolo D, Hogden MC, Hoyng CB, Webster AR, Cremers FPM, Cheetham ME, Garanto A, Collin RWJ.
PMID: 32653833
Mol Ther Nucleic Acids. 2020 Sep 04;21:412-427. doi: 10.1016/j.omtn.2020.06.007. Epub 2020 Jun 12.

Stargardt disease is a progressive retinal disorder caused by bi-allelic mutations in the ABCA4 gene that encodes the ATP-binding cassette, subfamily A, member 4 transporter protein. Over the past few years, we and others have identified several pathogenic variants...

Cite
Khan M, Arno G, Fakin A, et al. Detailed Phenotyping and Therapeutic Strategies for Intronic ABCA4 Variants in Stargardt Disease. Mol Ther Nucleic Acids. 2020;21:412-427doi: 10.1016/j.omtn.2020.06.007.
Khan, M., Arno, G., Fakin, A., Parfitt, D. A., Dhooge, P. P. A., Albert, S., Bax, N. M., Duijkers, L., Niblock, M., Hau, K. L., Bloch, E., Schiff, E. R., Piccolo, D., Hogden, M. C., Hoyng, C. B., Webster, A. R., Cremers, F. P. M., Cheetham, M. E., Garanto, A., & Collin, R. W. J. (2020). Detailed Phenotyping and Therapeutic Strategies for Intronic ABCA4 Variants in Stargardt Disease. Molecular therapy. Nucleic acids, 21412-427. https://doi.org/10.1016/j.omtn.2020.06.007
Khan, Mubeen, et al. "Detailed Phenotyping and Therapeutic Strategies for Intronic ABCA4 Variants in Stargardt Disease." Molecular therapy. Nucleic acids vol. 21 (2020): 412-427. doi: https://doi.org/10.1016/j.omtn.2020.06.007
Khan M, Arno G, Fakin A, Parfitt DA, Dhooge PPA, Albert S, Bax NM, Duijkers L, Niblock M, Hau KL, Bloch E, Schiff ER, Piccolo D, Hogden MC, Hoyng CB, Webster AR, Cremers FPM, Cheetham ME, Garanto A, Collin RWJ. Detailed Phenotyping and Therapeutic Strategies for Intronic ABCA4 Variants in Stargardt Disease. Mol Ther Nucleic Acids. 2020 Sep 04;21:412-427. doi: 10.1016/j.omtn.2020.06.007. Epub 2020 Jun 12. PMID: 32653833; PMCID: PMC7352060.
Copy Download .nbib Format: NLM
Morpho-Orthographic Complexity in Affix Spelling in Hebrew: A Novel Psycholinguistic Outlook Across the School Years.

Frontiers in psychology

Schiff R, Rosenstock S, Ravid D.
PMID: 32528348
Front Psychol. 2020 May 26;11:868. doi: 10.3389/fpsyg.2020.00868. eCollection 2020.

The current study examined the factors underlying native Hebrew speakers' ability to learn homophonous affix spelling. It takes a novel view in investigating the effect of morpho-orthographic complexity of affix representation on the development of affix spelling across the...

Cite
Schiff R, Rosenstock S, Ravid D. Morpho-Orthographic Complexity in Affix Spelling in Hebrew: A Novel Psycholinguistic Outlook Across the School Years. Front Psychol. 2020;11:868doi: 10.3389/fpsyg.2020.00868.
Schiff, R., Rosenstock, S., & Ravid, D. (2020). Morpho-Orthographic Complexity in Affix Spelling in Hebrew: A Novel Psycholinguistic Outlook Across the School Years. Frontiers in psychology, 11868. https://doi.org/10.3389/fpsyg.2020.00868
Schiff, Rachel, et al. "Morpho-Orthographic Complexity in Affix Spelling in Hebrew: A Novel Psycholinguistic Outlook Across the School Years." Frontiers in psychology vol. 11 (2020): 868. doi: https://doi.org/10.3389/fpsyg.2020.00868
Schiff R, Rosenstock S, Ravid D. Morpho-Orthographic Complexity in Affix Spelling in Hebrew: A Novel Psycholinguistic Outlook Across the School Years. Front Psychol. 2020 May 26;11:868. doi: 10.3389/fpsyg.2020.00868. eCollection 2020. PMID: 32528348; PMCID: PMC7264861.
Copy Download .nbib Format: NLM
Adverse Events Following Minimally Invasive Achilles Tendon Repair.

Foot & ankle specialist

Idarraga AJ, Bohl DD, Barnard E, Movassaghi K, Hamid KS, Schiff AP.
PMID: 32840128
Foot Ankle Spec. 2020 Aug 25;1938640020950895. doi: 10.1177/1938640020950895. Epub 2020 Aug 25.

BACKGROUND: The rate of wound complications following traditional open Achilles tendon repair is reported at 7.6%. The purpose of this study is to characterize the rate of wound and other early complications following a specific minimally invasive Achilles tendon...

Cite
Idarraga AJ, Bohl DD, Barnard E, et al. Adverse Events Following Minimally Invasive Achilles Tendon Repair. Foot Ankle Spec. 2020;1938640020950895doi: 10.1177/1938640020950895.
Idarraga, A. J., Bohl, D. D., Barnard, E., Movassaghi, K., Hamid, K. S., & Schiff, A. P. (2020). Adverse Events Following Minimally Invasive Achilles Tendon Repair. Foot & ankle specialist, 1938640020950895. https://doi.org/10.1177/1938640020950895
Idarraga, Alexander J, et al. "Adverse Events Following Minimally Invasive Achilles Tendon Repair." Foot & ankle specialist vol. (2020): 1938640020950895. doi: https://doi.org/10.1177/1938640020950895
Idarraga AJ, Bohl DD, Barnard E, Movassaghi K, Hamid KS, Schiff AP. Adverse Events Following Minimally Invasive Achilles Tendon Repair. Foot Ankle Spec. 2020 Aug 25;1938640020950895. doi: 10.1177/1938640020950895. Epub 2020 Aug 25. PMID: 32840128.
Copy Download .nbib Format: NLM
A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer.

Journal of clinical medicine

Thangavel H, De Angelis C, Vasaikar S, Bhat R, Jolly MK, Nagi C, Creighton CJ, Chen F, Dobrolecki LE, George JT, Kumar T, Abdulkareem NM, Mao S, Nardone A, Rimawi M, Osborne CK, Lewis MT, Levine H, Zhang B, Schiff R, Giuliano M, Trivedi MV.
PMID: 31652963
J Clin Med. 2019 Oct 24;8(11). doi: 10.3390/jcm8111772.

Circulating tumor cell clusters (CTCcl) have a higher metastatic potential compared to single CTCs and predict long-term outcomes in breast cancer (BC) patients. Because of the rarity of CTCcls, molecular characterization of primary tumors that give rise to CTCcl...

Cite
Thangavel H, De Angelis C, Vasaikar S, et al. A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer. J Clin Med. 2019;8(11)doi: 10.3390/jcm8111772.
Thangavel, H., De Angelis, C., Vasaikar, S., Bhat, R., Jolly, M. K., Nagi, C., Creighton, C. J., Chen, F., Dobrolecki, L. E., George, J. T., Kumar, T., Abdulkareem, N. M., Mao, S., Nardone, A., Rimawi, M., Osborne, C. K., Lewis, M. T., Levine, H., Zhang, B., Schiff, R., Giuliano, M., & Trivedi, M. V. (2019). A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer. Journal of clinical medicine, 8(11), . https://doi.org/10.3390/jcm8111772
Thangavel, Hariprasad, et al. "A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer." Journal of clinical medicine vol. 8,11 (2019). doi: https://doi.org/10.3390/jcm8111772
Thangavel H, De Angelis C, Vasaikar S, Bhat R, Jolly MK, Nagi C, Creighton CJ, Chen F, Dobrolecki LE, George JT, Kumar T, Abdulkareem NM, Mao S, Nardone A, Rimawi M, Osborne CK, Lewis MT, Levine H, Zhang B, Schiff R, Giuliano M, Trivedi MV. A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer. J Clin Med. 2019 Oct 24;8(11). doi: 10.3390/jcm8111772. PMID: 31652963; PMCID: PMC6912280.
Copy Download .nbib Format: NLM
A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy.

Cancers

Chin RI, Schiff JP, Brenneman RJ, Gay HA, Thorstad WL, Lin AJ.
PMID: 34771432
Cancers (Basel). 2021 Oct 20;13(21). doi: 10.3390/cancers13215269.

Radiotherapy plays an important role in the definitive and adjuvant treatment of head and neck squamous cell carcinoma (HNSCC). However, standard courses of radiation therapy may contribute to the depletion of circulating lymphocytes and potentially attenuate optimal tumor antigen...

Cite
Chin RI, Schiff JP, Brenneman RJ, et al. A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy. Cancers (Basel). 2021;13(21)doi: 10.3390/cancers13215269.
Chin, R. I., Schiff, J. P., Brenneman, R. J., Gay, H. A., Thorstad, W. L., & Lin, A. J. (2021). A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy. Cancers, 13(21), . https://doi.org/10.3390/cancers13215269
Chin, Re-I, et al. "A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy." Cancers vol. 13,21 (2021). doi: https://doi.org/10.3390/cancers13215269
Chin RI, Schiff JP, Brenneman RJ, Gay HA, Thorstad WL, Lin AJ. A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy. Cancers (Basel). 2021 Oct 20;13(21). doi: 10.3390/cancers13215269. PMID: 34771432; PMCID: PMC8582444.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 203 entries